Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society COMMENTS Vasodilator Actions of Urocortin and Related Peptides in the Human Perfused Placenta in Vitro*

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Secretion of placental peptide hormones: functions and trafficking

  2025cites this paper
• Urocortins as biomarkers in cardiovascular disease.

  2021cites this paper
• Placental Production of Peptide, Steroid, and Lipid Hormones

  2020cites this paper
• Endocrinology of Human Pregnancy and Fetal-Placental Neuroendocrine Development

  2019cites this paper
• Role of urocortin in pregnancy: An update and future perspectives.

  2016cites this paper
• Expression of urocortin and corticotrophin-releasing hormone receptor-2 in patients with intrahepatic cholestasis of pregnancy.

  2014cites this paper
• New insights into the mechanisms underlying vascular and cardiac effects of urocortin.

  2013cites this paper
• Distribution of Urocortins and Corticotropin-Releasing Factor Receptors in the Cardiovascular System

  2012cites this paper
• Estrogenic action on arterial smooth muscle: permissive for maintenance of CRHR2 expression.

  2012cites this paper
• RelB/NF-κB2 regulates corticotropin-releasing hormone in the human placenta.

  2012cites this paper
• Corticotrophin-releasing factor and urocortin inhibit system A activity in term human placental villous explants.

  2011cites this paper
• Urocortin‐2 induces vasorelaxation of coronary arteries isolated from patients with heart failure

  2011cites this paper
• Neuroendocrine mechanisms in pregnancy and parturition.

  2010cites this paper
• The role of urocortin in gynecological and obstetrical conditions

  2009cites this paper
• Urocortin in Second Trimester Amniotic Fluid: Its Role as Predictor of Preterm Labor

  2009cites this paper
• Placental urocortins and CRF in late gestation.

  2009cites this paper
• Urocortin inhibits mesenteric arterial remodeling in spontaneously hypertensive rats.

  2009cites this paper
• Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation

  2008cites this paper
• The Increase of Blood Flow in the Fetal Middle Cerebral Artery Correlates With the Onset of Labor at Term

  2008cites this paper
• Stress and Pregnancy: CRF as Biochemical Marker

  2008cites this paper
• Urocortin induces endothelium-dependent vasodilatation and hyperpolarization of rat mesenteric arteries by activating Ca2+-activated K+ channels.

  2007cites this paper
• Expression of urocortin in the extravillous human trophoblast at the implantation site.

  2007cites this paper
• Eferências do núcleo lateral superior da oliva no rato (rattus norvegicus).

  2007cites this paper
• Cardioprotective Action of Urocortin in Early Pre‐ and Postconditioning

  2007cites this paper
• High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension

  2006cites this paper
• Hormonal regulation of placental nitric oxide and pathogenesis of pre-eclampsia.

  2006cites this paper
• CHAPTER 53 – Placental Endocrine Function

  2006cites this paper
• Urocortin increases the intracellular cAMP concentration and thus decreases the degree of phosphorylation of MYPT1 and increases the myosin phosphatase activity

  2006cites this paper
• Microvascular effects of corticotropin-releasing hormone in human skin vary in relation to estrogen concentration during the menstrual cycle.

  2005cites this paper
• Urocortin-induced relaxation in the human internal mammary artery.

  2005cites this paper
• Reduced Maternal Plasma Urocortin Concentrations and Impaired Uterine Artery Blood Flow at Human Mid Pregnancy

  2005cites this paper
• Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides.

  2005cites this paper
• Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats.

  2005cites this paper
• Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure.

  2005cites this paper
• Urocortin and cardiovascular protection.

  2004cites this paper
• The relaxant effect of urocortin in rat pulmonary arteries.

  2004cites this paper
• Urocortins in human reproduction.

  2004cites this paper
• The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia.

  2004cites this paper
• Effect of Hypoxia on Urocortin Production in Human Gestational Trophoblasts In Vitro

  2004cites this paper
• Urocortin hyperpolarizes stomach smooth muscle via activation of Ca2+-sensitive K+ currents

  2004cites this paper
• Relaxation of rat arteries by urocortin: effects of gender and diabetes

  2003cites this paper
• elaxation by urocortin of rat renal arteries : effects of diabetes in males and females ́ ́ ́

  2003cites this paper
• Regional haemodynamic effects of urocortin in the anaesthetized rat.

  2003cites this paper
• Regulation of Umbilical Blood Flow

  2003cites this paper
• Roles of cyclic AMP and Ca2+-activated K+ channels in endothelium-independent relaxation by urocortin in the rat coronary artery.

  2003cites this paper
• Mechanisms of relaxation by urocortin in renal arteries from male and female rats

  2003cites this paper
• Relaxation by urocortin of rat renal arteries: effects of diabetes in males and females.

  2003cites this paper
• Impaired Uterine Artery Blood Flow at Mid Gestation and Low Levels of Maternal Plasma Corticotropin-Releasing Factor

  2003cites this paper
• Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A.

  2003cites this paper
• Microvascular effects of CRH in human skin vary in relation to gender.

  2002cites this paper
• Relaxation by urocortin of human saphenous veins

  2002cites this paper
• Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma

  2002cites this paper
• Placental stress factors and maternal-fetal adaptive response

  2002cites this paper
• Role of stress peptides during human pregnancy and labour.

  2002cites this paper
• Urocortin‐induced endothelium‐dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels

  2002cites this paper
• Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.

  2002cites this paper
• Identification of urocortin mRNA and peptide in the human endometrium.

  2002cites this paper
• Urocortin has cell-proliferative effects on cardiac non-myocytes.

  2002cites this paper
• The placenta as a neuroendocrine organ.

  2001cites this paper
• Characterising the Corticotropin-releasing Hormone (CRH) Receptors Mediating CRH and Urocortin Actions During Human Pregnancy and Labour

  2001cites this paper
• Human Placenta as a Source of Neuroendocrine Factors

  2001cites this paper
• Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA.

  2000cites this paper
• Effect of acute and subchronic subcutaneous urocortin on blood pressure and food consumption in ob/ob mice.

  2000cites this paper
• Localization and characterization of urocortin during human pregnancy.

  2000influential citation
• Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.

  2000cites this paper
• Urocortin Expression in Rat Brain: Evidence Against a Pervasive Relationship of Urocortin‐Containing Projections With Targets Bearing Type 2 CRF Receptors

  1999cites this paper
• Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor.

  1999cites this paper
• Corticotropin-releasing hormone stimulates P450 17alpha-hydroxylase/17,20-lyase in human fetal adrenal cells via protein kinase C.

  1999cites this paper